BIO-key International Inc. BKYI

BIO-key's Passkey:YOU authenticator has earned FIDO Alliance Full Certification (Security Assurance Level L1, CTAP v2.0) to work with FIDO2/WebAuthn passkeys across enterprise platforms, including Entra ID, Okta, Ping, Duo, and PortalGuard, plus websites. The system uses a shared workstation fingerprint scanner or a carried door-access badge—no phones or separate hardware tokens required—and enrollment works across devices and locations. It targets environments where phones are restricted or devices are shared, such as manufacturing floors, air-gapped networks, call centers, retail counters, and healthcare. Central management gives visibility to security teams, enabling approval, revocation, and monitoring of relying parties, unlike traditional hardware keys. BIO-key emphasizes biometric data encryption and compliance with NIST 800-63 and GDPR. The release highlights governance benefits for Agentic AI controls and could unlock new enterprise markets. Certified, interoperable, phishing-resistant authentication with centralized governance could significantly expand enterprise reach and AI-control applicability.

BIO-key International Inc. (BKYI) released its Q2 2026 earnings call transcript covering quarterly financial results and business updates. Quarterly earnings details and guidance typically produce moderate short-term effects on company valuation and trading activity.

BIO-key International Inc reported a 53% surge in license revenue for Q2 2026. License revenue growth signals improved core performance with potential short-term market effects.

BIO-key International Inc. held Q2 2026 earnings call covering quarterly financial results, revenue figures, operational updates and forward outlook. Quarterly earnings data directly shapes near-term valuation and investor positioning for the company.

BIO-key International reported 13% Q2 revenue growth and 51% bottom line improvement driven by strength with government, defense, and financial sector customers globally. Earnings call scheduled for tomorrow at 10am ET. Q2 revenue growth and profit improvement signal positive financial trends but remain limited in altering long-term trajectory.

Portuguese National Security Agency selects BIO-key International and Visualforma to strengthen identity security. Win with Portuguese National Security Agency marks major government contract that expands BIO-key international footprint and supports revenue growth.

BIO-key International Inc. partners with Maktabi Tech to advance identity security across Saudi Arabia’s education sector. Partnership targets identity security expansion in Saudi education sector and may moderately lift BKYI regional revenue prospects.

Central Bank of Jordan selects BIO-key International Inc. for national biometric authentication initiative. National-level biometric contract win expands BIO-key revenue base and international footprint substantially.

BIO-key International Inc. held its Q1 2026 earnings call, reporting quarterly financial results along with operational updates and forward-looking commentary on business performance. Quarterly earnings figures and guidance can influence near-term investor sentiment and valuation but rarely reshape long-term company trajectory on their own.

BIO-key International Inc (BKYI) posted a sharp revenue increase in Q1 2026, driven by strategic initiatives detailed during its earnings call. Revenue surge combined with strategic updates signals material improvement in financial trajectory and investor outlook.

BIO-key International reported 34% higher Q1 revenue with an improved bottom line and projects Q2 profitability on 65% revenue growth; investor call today at 10am ET. Q1 revenue gains plus expected Q2 profitability point to stronger financial trajectory and heightened investor interest.

BIO-key International Inc. (BKYI) shares will temporarily move to OTC Markets starting Wednesday, May 13th, after Nasdaq suspension following today's market close; the company is working to restore its Nasdaq listing expeditiously. Nasdaq suspension and shift to OTC markets significantly harms stock liquidity, trading visibility, and investor sentiment despite restoration efforts.

BIO-key International Inc. (BKYI) received a Nasdaq notice of non-compliance due to delaying its Form 10-K filing for the fiscal year ended December 31, 2023. The company has until August 5, 2024, to submit the filing or face potential delisting proceedings. BIO-key plans to file the 10-K as soon as possible. Nasdaq non-compliance notice for delayed 10-K filing risks delisting and negatively impacts short-term market sentiment and financial compliance perception.

BIO-key International Inc. (BKYI) expects a 50% increase in first-half revenues, driving profitability in the period. Expecting 50% revenue growth and first-half profitability signals a major financial turnaround with strong potential to boost investor sentiment and stock performance.

BIO-key International Inc. (BKYI) Q4 2025 earnings call summary covers quarterly financial results, operational highlights, and future outlook. Q4 earnings call details financial performance and guidance, significantly influencing investor sentiment and stock trajectory.

BIO-key International Inc. (BKYI) Q4 2025 earnings call highlights navigating challenges amid operational hurdles and strategic adjustments. Q4 earnings highlights reveal challenges directly influencing BKYI's financial performance and strategic trajectory.

BIO-key International Inc. (BKYI) reported 2025 results with substantially improved cash position, supporting expected strong growth in 2026. Investor call today at 10am ET. Improved cash position and 2026 growth expectations signal significant positive shift in BKYI's financial health and market trajectory.

TD SYNNEX deepens partnership with BIO-key International to enhance public sector security using BIO-key's biometric authentication solutions like PortalGuard and biometric ID software. The deal expands distribution through TD SYNNEX's government-focused channels, targeting federal, state, and local agencies amid rising cybersecurity demands. Strategic alliance with major distributor TD SYNNEX opens access to high-value public sector market, likely boosting BIO-key's revenue and market position significantly.

BIO-key International Inc. partners with TD SYNNEX Public Sector (DLT) to deliver identity-bound biometric and identity access management (IAM) solutions to the U.S. public sector, leveraging DLT's established government distribution network to expand market reach. Partnership unlocks U.S. public sector distribution channel, positioning BIO-key for significant revenue growth and enhanced competitive standing in government biometrics and IAM markets.

BIO-key International Inc. (BKYI) surpassed $2 million in military and defense sales over the last 12 months, including a follow-on order from a foreign defense ministry, as geopolitical tensions elevate the need to secure intelligence against cyber threats. Surpassing $2M in defense sales with a follow-on foreign ministry order amid geopolitical tensions signals major revenue growth and strategic validation in a high-value sector.

Retail bank executes expanded $1.04M license renewal for BIO-key International's biometric identity solution serving 30 million clients. Expanded $1.04M renewal with major bank validates BIO-key's technology across 30M users and secures significant recurring revenue.

BIO-key International and RunLevel are strengthening identity security across Mozambique’s national payments infrastructure for Sociedade Interbancária de Moçambique (SIMO). Securing national payments infrastructure in Mozambique via partnership expands BIO-key's international footprint and biometric authentication deployments.

BIO-key International Inc.'s EMEA subsidiary has partnered with Citadel Global to enhance its presence in India and promote the adoption of biometric identity solutions. This collaboration aims to support the EU–India Free Trade Agreement, indicating a strategic move to expand market reach and capitalize on growing demand for biometric technologies in the region. The partnership with Citadel Global is a significant strategic move that could enhance BIO-key's market position and growth prospects in India.

BIO-key International Inc. and Visualforma have secured a contract to provide digital identity solutions for a large municipality in Portugal. This partnership aims to enhance security and streamline access to digital services for the municipality's residents, leveraging BIO-key's biometric technology. The contract represents a significant strategic move that could enhance BIO-key's market position and revenue potential.

BIO-key International Inc. (BKYI) has been highlighted as one of the most active stocks in the market, indicating increased trading volume and investor interest. The company's performance may be influenced by recent developments in the biometric technology sector, where it operates. Investors are closely monitoring BKYI's strategic initiatives and market positioning as they assess future growth potential. Increased trading activity suggests moderate investor interest, which may influence market sentiment and performance.

BIO-key International Inc. introduced new passwordless authentication innovations at the 2025 Gartner IAM Summit in North America, addressing the growing demand for secure and modern authentication solutions. These innovations aim to enhance user experience while improving security measures, positioning BIO-key as a leader in the identity and access management sector. The introduction of passwordless innovations is a significant strategic move that could enhance BIO-key's competitive positioning and market appeal.

BIO-key International Inc. (BKYI) reported its Q3 2025 earnings, highlighting challenges faced in the current market environment. The company discussed its strategic initiatives aimed at overcoming these obstacles, including product innovation and operational adjustments. Despite the difficulties, management expressed optimism about future growth opportunities and emphasized their commitment to enhancing customer engagement and expanding market reach. Challenges and strategic initiatives discussed may moderately influence financial performance and competitive positioning.

BIO-key International Inc. has partnered with SAVIS Group to introduce its identity and biometric authentication solutions in Vietnam. This collaboration aims to enhance security and streamline access control in various sectors, including government and enterprise. The partnership is expected to leverage BIO-key's advanced technology to meet the growing demand for secure identity verification in the region. The partnership with SAVIS Group represents a significant strategic move that could enhance BIO-key's market presence and revenue potential in Vietnam.

BIO-key International Inc. (BKYI) reported its Q3 results, highlighting an improved balance sheet aimed at supporting growth goals for 2026. The company is set to hold an investor call at 10am ET today to discuss these developments. The enhanced balance sheet and growth goals indicate a moderately noticeable influence on future performance.

BIO-key International Inc. (BKYI) has been identified as one of the most active stocks in the market, indicating heightened trading activity and interest among investors. This surge in activity may reflect broader market trends or specific developments related to the company, potentially influencing its stock performance and investor sentiment. Increased trading activity suggests a moderately noticeable influence on market sentiment and potential financial performance.